Les pyrénées Catalanes dans la région de l'Empordà. Relations entre zones isopiques crétacées et unités structurales

Se describen las series estratigráficas cretácicas de las diferentes unidades estructurales del "Tronçon Catalan" de los Pirineos (Región del Empordà). La reconstitución paleogeográfica deducida pone en evidencia un área de sedimentación sobre el margen ibérico, abierta hacia el Noroeste. Las series más completas de este dominio están hoy corridas hacia el Suroeste en los mantos del Alt Empordà; las series reducidas de borde están también implicadas en una tectónica tangencial, con despegues intercutáneos, en la unidad sinclinal de Olot

Fluctuation-Dissipation Relations of a Tunnel Junction Driven by a Quantum Circuit

We derive fluctuation-dissipation relations for a tunnel junction driven by a high impedance microwave resonator, displaying strong quantum fluctuations. We find that the fluctuation-dissipation relations derived for classical forces hold, provided the effect of the circuit's quantum fluctuations is incorporated into a modified non-linear $I(V)$ curve. We also demonstrate that all quantities measured under a coherent time dependent bias can be reconstructed from their dc counterpart with a photo-assisted tunneling relation. We confirm these predictions by implementing the circuit and measuring the dc current through the junction, its high frequency admittance and its current noise at the frequency of the resonator.Comment: Publisehd as Physical Review Letters, 114, 12680

ARTICLE Photon-assisted tunnelling with nonclassical light

International audienceAmong the most exciting recent advances in the field of superconducting quantum circuits is the ability to coherently couple microwave photons in low-loss cavities to quantum electronic conductors. These hybrid quantum systems hold great promise for quantum information-processing applications; even more strikingly, they enable exploration of new physical regimes. Here we study theoretically the new physics emerging when a quantum electronic conductor is exposed to nonclassical microwaves (for example, squeezed states, Fock states). We study this interplay in the experimentally relevant situation where a superconducting microwave cavity is coupled to a conductor in the tunnelling regime. We find that the conductor acts as a nontrivial probe of the microwave state: the emission and absorption of photons by the conductor is characterized by a nonpositive definite quasi-probability distribution, which is related to the Glauber-Sudarshan P-function of quantum optics. These negative quasi-probabilities have a direct influence on the conductance of the conductor

Finite frequency noise in a quantum point contact between helical edge states

We propose and analyze the non-equilibrium finite frequency current-current correlations as a mean to characterize the helical nature of the edge states in a quantum spin hall geometry. We show that the finite frequency noise enables to unambiguously discriminate between the one-particle and the two-particles processes occurring in the helical liquid for both tunneling or weak-backscattering regimes.Comment: 5 pages, 5 figure

Des possibilités d'emploi du sperme de taureau transporté de France pour l'insémination artificielle dans les territoires d'Outre-mer

Aucun résumé disponible

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib inspecial non-small-cell lung cancer patient populations

Some subgroups of patients with advanced/metastatic non-small-cell lung cancer (NSCLC) are frequently considered ineligible for the aggressive, platinum-based combination chemotherapy that is the recommended treatment. Elderly patients may have a poorer tolerance of chemotherapy due to impaired organ function and frequent comorbidities; patients with poor performance status (PS; greater than or equal to2 due to NSCLC and/or coexisting illnesses) are often considered unfit for chemotherapy; other patients may be unable or unwilling to endure the toxicity or inconvenience of chemotherapy. These patient groups may benefit from novel, relatively nontoxic treatment modalities. Gefitinib (Iressa, ZD1839) 250 mg day(-1) is well tolerated and has proven antitumour and symptom improvement activity in patients with previously treated NSCLC. Phase II trials (IDEAL 1 and 2) of gefitinib in advanced/metastatic NSCLC included 70 out of 425 (16.5%) patients with PS greater than or equal to2, and their response rate, clinical benefit rate and rates of adverse events were similar to those of the overall trial population. In addition, many patients with advanced/metastatic NSCLC with poor PS or advanced age have received gefitinib 250 mg day(-1) in an Expanded Access Programme (EAP). Observations from the EAP support those of IDEAL 1 and 2, and indicate that gefitinib 250 mg day(-1) warrants further investigation in these patient groups

Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study

We conducted a phase II trial of triplet chemotherapy consisting of vinorelbine, gemcitabine, and cisplatin in patients with advanced non-small cell lung cancer to assess its efficacy and toxicity. Thirty-three patients with chemotherapy-naïve stage IIIB disease (n=8), stage IV disease (n=23), or recurrence after surgical resection (n=2) were given intravenous infusions of vinorelbine 25 mg m−2, gemcitabine 1000 mg m−2, and cisplatin 40 mg m−2 on days 1 and 8 at 3-week intervals. There were 16 partial responses, and the objective response rate was 48% (95% confidence interval: 31–66%). The median survival time was 13.5 months (95% confidence interval: 10.6–16.4 months), and the one-year survival rate was 61%. Grade 4 haematologic toxicity consisted of neutropenia in 72% of patients, and febrile neutropenia occurred in 42% of the patients. There was one toxic death, and it was attributed to neutropenic fever and haemoptysis. Autopsy revealed diffuse pulmonary haemorrhage secondary to bacterial abscesses and vasculitis in both lungs. The common nonhaematologic toxicities included grade 2–3 nausea (39%) and vomiting (18%). Triplet chemotherapy containing vinorelbine, gemcitabine, and cisplatin is effective in the treatment of chemo-näive patients with advanced non-small cell lung cancer, but produces unacceptable frequent febrile neutropenia